BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:8f89e104a9b369b922c2c37b6974ba0f
DTSTAMP:20260807T162342Z
SUMMARY:David Sjöström - Institutionen för kliniska vetenskaper\, Lund
DESCRIPTION:Kontakt: david.sjostrom@med.lu.se\n\nTitle: Psychedelic Use and
  Mental Health in AdolescentsMain supervisor: Docent Emma Claesdotter-Knut
 sson\, Lunds universitet&nbsp\;Reviewers: Professor Anette Kjellgren\, Kar
 lstad Universitet and Phd Claudia Cicognola\, Lunds universitetAbstract&nb
 sp\;BackgroundResearch on classical psychedelics has expanded rapidly in r
 ecent years\, with clinical trials in adults suggesting benefits for depre
 ssion\, anxiety\, substance use disorders and eating disorders. Far less i
 s known about psychedelic use in adolescents and associations with mental 
 health\, despite indications of rising prevalence. Adolescence is a sensit
 ive developmental period\, marked by ongoing brain maturation and psychoso
 cial vulnerability\, which may shape responses to psychoactive substances.
  Previous findings suggest that adolescents may experience more adverse ef
 fects\, including anxiety and destabilizing experiences\, compared with ad
 ults. Personality traits\, particularly neuroticism\, appear to play a cru
 cial role in explaining both mental health outcomes and the nature of psyc
 hedelic experiences. To date\, no randomized controlled trial has been con
 ducted in adolescent populations.Research QuestionsI. What does the existi
 ng literature show about adolescent psychedelic use and its associations w
 ith mental health?II. What is the prevalence of psychedelic use among Swed
 ish adolescents?III. How do adolescents describe their lived experiences w
 ith psychedelics\, including perceived benefits\, challenges\, and integra
 tion into everyday life?IV. How do adolescent and adult psychedelic users 
 differ in reported outcomes\, and what role does personality play in expla
 ining these differences?V. Can psilocybin be studied safely in adolescents
  with anorexia nervosa\, and how should a protocol be designed to ensure e
 thical and developmental safeguards?Preliminary ResultsThe scoping review 
 revealed sparse and methodologically limited research and a lack of contro
 lled trials in adolescents. The National Swedish School Survey (Research Q
 uestion I)) showed that 1\,9% of adolescents reported lifetime use of psyc
 hedelics\, and they reported higher anxiety\, largely explained by neuroti
 cism rather than use itself. Research Question IV results are&nbsp\; in re
 view and demonstrate the adolescents report more adverse outcomes than adu
 lts\, and that personality traits explain of the variance than age alone. 
 Results regarding Research Question III and V is being prepared for submis
 sion.&nbsp\;SignificanceThis research program provides novel insights into
  adolescent psychedelic use\, emphasizing the importance of personality tr
 aits\, developmental stage\, and contextual factors in shaping outcomes. T
 he findings highlight both risks and therapeutic potential\, underscoring 
 the need for longitudinal\, ethically sound\, and developmentally informed
  research. By combining epidemiological\, qualitative\, and clinical trial
  approaches\, this thesis contributes knowledge essential for public healt
 h\, harm reduction\, and the future development of safe psychedelic-assist
 ed therapies for adolescents.PublicationsSjöström\, D. K.\, Claesdotter-
 Knutsson\, E.\, Gripe\, I.\, Thor\, S.\, &amp\; Kajonius\, P. J. (2025).&n
 bsp\;Adolescent psychedelic use and mental health is associated with user 
 personality: A representative national study on drug use. International Jo
 urnal of Mental Health and Addiction. Advance online publication.&nbsp\;ht
 tps://doi.org/10.1007/s11469-025-01481-7Sjöström\, D. K.\, Claesdotter-K
 nutsson\, E.\, &amp\; Kajonius\, P. J.&nbsp\;Adverse outcomes following ps
 ychedelic use in adolescents and adults: Associations with age and persona
 lity traits [Manuscript submitted for publication 2025.09.23]\n\nMer infor
 mation om händelsen: https://www.intramed.lu.se/evenemang/david-sjostrom-
 institutionen-kliniska-vetenskaper-lund
DTSTART;TZID=GMT:20251013T110000
DTEND;TZID=GMT:20251013T110000
LOCATION:Allhelgona Kyrkogata 16A\, rum  P124\, Psykologiska Institutionen\
 , Lunds Universitet
END:VEVENT
END:VCALENDAR
